secwatch / observer
8-K filed April 3, 2023, 7:59 PM ET ticker TCRT CIK 0001107421
debt confidence high sentiment neutral materiality 0.60

Alaunos Therapeutics amends SVB loan agreement; raises cash collateral requirement eases account covenant

Alaunos Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Alaunos Therapeutics, Inc. amended Third Amendment with lenders party thereto and Silicon Valley Bank (SVB), a division of First-Citizens Bank & Trust Company (effective 2023-03-30).

Action
amendment
Agreement
credit facility
Counterparty
lenders party thereto and Silicon Valley Bank (SVB), a division of First-Citizens Bank & Trust Company
Effective
2023-03-30
Exact text from the filing
Third Amendment to the Loan and Security Agreement Effective March 30, 2023, Alaunos Therapeutics, Inc. (the “Company”), as borrower, entered into a Third Amendment (the “Amendment”) to the Loan and Security Agreement, dated August 6, 2021, as previously amended (the “Original Agreement” and, as amended by the Amendment, the “Amended Agreement”), by and among the Company, the lenders party thereto and Silicon Valley Bank (“SVB”), a division of First-Citizens Bank & Trust Company (successor by purchase to the Federal Deposit Insurance Corporation as Receiver for Silicon Valley Bridge Bank, N.A. (as successor to SVB)), as administrative agent and collateral agent.
View on SEC.gov

Browse all material agreements →

Alaunos Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-088948
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.